Phacilitate’s Portfolio Director Michael Adeniya shares insights from his call with Dark Horse’s CEO Anthony Davies as he encourages the industry to continue innovating and adapting. Click here for Michael’s message.…

by Gareth Macdonald

The cell therapy sector faces a cost of goods sold (COGS) crisis and needs to get beyond the “product is the process” mind-set says Anthony Davies, CEO of Dark Horse Consulting.

Cell and gene therapies have attracted …

SAN FRANCISCO /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth oriented private equity firm with $1.5 billion of capital under management, today announced the formation of a strategic relationship with Dark Horse Consulting Group (“Dark Horse” or “the Company”).  Taking …

Campbell, CA, May 28 2019 – Dark Horse Consulting Group, the leading global consultancy practice specializing in cell and gene therapy product development, will participate in the 2019 International Society for Cell and Gene Therapy Annual Meeting during May 29 …

Campbell, CA, May 21, 2019 – Dark Horse Consulting Group (DHC), the leading global consultancy practice specializing in cell and gene therapy product development, will participate in the 2019 Alliance for Regenerative Medicine (ARM) Cell & Gene Forum & Legislative …

London, UK, May 15, 2019 – Dark Horse Consulting Group (DHC), the leading global consultancy practice specializing in cell and gene therapy product development, announced its participation in the Frost & Sullivan Executive Think Tank on Current challenges and future …

May 2019 – Dark Horse Consulting (DHC) is proud to announce the recent addition of three full time consultants to our team.  Each of the new hires were carefully selected for their best-in-class capabilities and experience in the Cell and …

Campbell, CA, April 29, 2019 – Dark Horse Consulting Group, the leading global consultancy practice specializing in cell and gene therapy product development, recently participated in the 2019 American Society of Gene and Cell Therapy 22nd Annual Meeting during April …

by Dan Stanton

Fully closed and automated platforms are key to reducing the current high costs of cell and gene therapy manufacturing, say industry experts.

Cell and gene therapies (CGTs) have come a long way over the past two years, …

by Dan Stanton

This is the first time in history that we can make more effective medicines than we can afford, says Dark Horse Consulting.

The Phacilitate conference took place in Miami this week, and in the plenary session Anthony …

Campbell, CA, January 21st, 2019 – Dark Horse Consulting, the leading consultancy specializing in cell and gene therapy product development, today announced its planned attendance and sponsorship of the 2019 Phacilitate Leaders World meeting, scheduled for January 22-25 in Miami, …